- Home
- LPTX vs IH Comparison
LPTX vs IH Comparison
Compare LPTX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- IH
- Stock Information
- Founded
- LPTX 2011
- IH 1996
- Country
- LPTX United States
- IH China
- Employees
- LPTX N/A
- IH N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- IH Other Consumer Services
- Sector
- LPTX Health Care
- IH Real Estate
- Exchange
- LPTX Nasdaq
- IH Nasdaq
- Market Cap
- LPTX 119.6M
- IH 123.1M
- IPO Year
- LPTX N/A
- IH 2020
- Fundamental
- Price
- LPTX $0.38
- IH $2.35
- Analyst Decision
- LPTX Buy
- IH
- Analyst Count
- LPTX 2
- IH 0
- Target Price
- LPTX $8.00
- IH N/A
- AVG Volume (30 Days)
- LPTX 321.1K
- IH 8.4K
- Earning Date
- LPTX 08-11-2025
- IH 07-01-2025
- Dividend Yield
- LPTX N/A
- IH 3.62%
- EPS Growth
- LPTX N/A
- IH N/A
- EPS
- LPTX N/A
- IH 0.25
- Revenue
- LPTX N/A
- IH $126,344,481.00
- Revenue This Year
- LPTX N/A
- IH $39.02
- Revenue Next Year
- LPTX N/A
- IH N/A
- P/E Ratio
- LPTX N/A
- IH $9.53
- Revenue Growth
- LPTX N/A
- IH N/A
- 52 Week Low
- LPTX $0.22
- IH $1.47
- 52 Week High
- LPTX $4.79
- IH $3.18
- Technical
- Relative Strength Index (RSI)
- LPTX 46.09
- IH 55.32
- Support Level
- LPTX $0.38
- IH $2.20
- Resistance Level
- LPTX $0.44
- IH $2.39
- Average True Range (ATR)
- LPTX 0.04
- IH 0.10
- MACD
- LPTX -0.00
- IH -0.01
- Stochastic Oscillator
- LPTX 22.52
- IH 91.90
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.